Holen Sie sich die Stockscreener-App
3.49
0.58%
0.02
Handel nachbörslich:
3.55
0.06
+1.72%
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
400.87%
44.85
|
8.955 | 17.08 | 4.235 | 6.507 |
Operating Expenses
|
13.84%
73.44
|
85.23 | 66.67 | 66.89 | 100.17 |
| Benefits Costs and Expenses |
17.20%
64.35
|
77.72 | 53.43 | 57.22 | 69.14 |
| Costs And Expenses |
17.20%
64.35
|
77.72 | 53.43 | 57.22 | 69.14 |
| Operating Income/Loss |
62.53%
-28.58
|
-76.28 | -49.59 | -62.66 | -93.66 |
| Nonoperating Income/Loss |
20.95%
9.083
|
7.51 | 13.24 | 9.676 | 31.03 |
| Income/Loss From Continuing Operations Before Tax |
71.65%
-19.50
|
-68.77 | -36.34 | -52.98 | -62.63 |
| Income Tax Expense/Benefit |
9.40%
-10.55
|
-11.65 | -1.617 | -7.363 | -11.53 |
| Income/Loss From Continuing Operations After Tax |
84.34%
-8.945
|
-57.12 | -34.73 | -45.62 | -51.11 |
|
Net Income/Loss
|
84.34%
-8.945
|
-57.12 | -34.73 | -45.62 | -51.11 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.89%
0.3409
|
298.88 | 298.51 | 297.69 | 294.85 |
| Diluted Average Shares |
99.89%
0.3409
|
298.88 | 298.51 | 297.69 | 294.85 |
| Basic Earnings Per Share |
84.21%
-0.03
|
-0.19 | -0.12 | -0.15 | -0.17 |
| Diluted Earnings Per Share |
84.21%
-0.03
|
-0.19 | -0.12 | -0.15 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):